Science Progress | Where science, technology, and progressive policy meet

Congress Deserves Better Info on Carbon Capture Technology

The Senate Subcommittee on Energy Oversight held a field hearing in Bismarck, North Dakota on Wednesday on carbon capture and sequestration technology. Two panels presented the current and projected future development of CCS technology, the outlook ranging from very cautious optimism to an almost cynical pessimism. But the lack of an objective scientific voice among those testifying was conspicuous.

Running the Numbers On R&D Earmarks

Colleges and universities received close to $2.25 billion from Congressional earmarks this year according to a new study released this week by The Chronicle of Higher Education. A large chunk, $1.6 billion, will go towards scientific research at some 500 institutions.

Broadband, Coming to a Rural Community Near You

The United States Department of Agriculture Rural Development Agency today announced a $267 million loan to Open Range Communications to bring portable, wireless broadband connectivity to rural areas in 17 states.

Britain Gets Creative About Innovation

British politician Gordon Brown has always been keen on creating innovation in his nation’s economy, convinced that U.K. universities and businesses together can create new technologies and services that will boost economic growth. Now that he’s prime minister of the United Kingdom, he’s moving swiftly to act on those inclinations—with possible lessons for the United States.

More Fuel for Debate: Biofuel Production Lowers the Cost of Oil

Worldwide biofuel production is increasing so rapidly, according to a new analysis from Merrill Lynch, while other fuel sources cannot keep up with demand, that without the rising production, oil prices would be higher than they already are. The Wall Street Journal reported on the analysis yesterday, which adds yet another variable to the already complex debate over biofuel policy.

Good Technology for the Classroom

Faculty and staff in colleges and universities have a growing number of technologies at their disposal, but they have to understand how to use them to enrich education, and institutions must be willing to invest in useful solutions.

The Dish: Sampling the Blogs

petri dishA quick look at some of the policy-related posts in the science and technology blogosphere: suggestions for best practices in science blogging; the need for more hurricane research; vaccines and public fears; and new research centers to study parallel computing.

The Ethics of Enhancing Brain Power

In a briefing yesterday for Capitol Hill staffers, neuroscientist Martha Farah explained that new technologies that enhance the power of the brain also raise questions about safety, economic fairness, privacy, and personal freedom.

FCC 700 mhz Auction Ends, Fun Begins

The FCC 700 mhz auction ended yesterday, raking in record $19.6 billion for Federal coffers. While the successful sale of the C-block triggers an “open” network provision, questions linger about the unsold D-block license and the future of a national emergency response network.

SCIENCE & SECURITY

The Halfway House Between Science and Secrets

A recent National Research Council report recognizes that the 9/11 attacks provoked counter-productive security measures that stifle access to fruitful scientific research. Security expert Bruce Schneier talks with Science Progress about the science that makes us smarter and the security that makes us safer.

FRAMING SCIENCE

Enablers

By constantly criticizing and responding to anti-science forces, are we only strengthening and propping them up?

The Dish: Sampling the Blogs

petri dishA quick look at some of the policy-related posts in the science and technology blogosphere: synthetic biology, the lack of science coverage on cable news networks, drug-resistant antibiotics, and rethinking the drug development process.

Bioscience Think Tank Leaders Outline Industry Financing Problems

Last week’s stories about the future of grants for the younger generation of NIH investigators is just one piece of the larger puzzle over the state of funding biotech research. The Scientist offers a useful summary of the major stumbling blocks in pharmaceutical development and how they relate to financing questions in the drug industry, in university labs, at the NIH, and at start-up companies.

Older